Zhuang Hongqing, Wei Feng, Jiang Liang, Wang Yuxia, Liu Zhongjun
Department of Radiation Oncology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, P.R. China.
Orthopedic Department, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, P.R. China.
Innovation (Camb). 2020 Aug 10;1(2):100040. doi: 10.1016/j.xinn.2020.100040. eCollection 2020 Aug 28.
To investigate the feasibility and early efficacy of 3D-printed vertebral body implantation combined with robotic radiosurgery in the treatment of spinal tumors. This study included 14 patients with spinal tumors from December 2017 to June 2018. Before surgery, all patients were subjected to CT scan and 3D data of the corresponding vertebral segments were collected. Titanium alloy formed 3D-printed vertebral body implantation and robotic stereotactic radiotherapy were performed because of the risk of postoperative residual, high risk of recovery, or recurrence after surgery. The main outcomes included the remission of symptoms, vertebral body stability, robotic stereotactic surgical precision, and local tumor control. All patients received complete and successful combination therapy, and all healed primarily without complications. The error of the coverage accuracy for robotic radiosurgery was less than 0.5 mm, and the error of the rotation angle was less than 0.5°. The therapeutic toxicity was limited (mainly in grades 1-2), and adverse events were uncommon. The evaluation of vertebral body stability and histocompatibility for all patients met the postoperative clinical requirements. For patients with post spinal injury, the pain symptoms were reduced or disappeared (93%), and nerve function was improved or even recovered after treatment (100%). During our follow-up period, most tumors were locally well controlled (93%). 3D- printed vertebral body implantation combined with robotic radiosurgery may offer a new treatment of spinal tumors. Chinese clinical trial registry: ChiCTR-ONN-17013946.
探讨3D打印椎体植入联合机器人放射外科治疗脊柱肿瘤的可行性及早期疗效。本研究纳入了2017年12月至2018年6月的14例脊柱肿瘤患者。术前,所有患者均接受CT扫描并收集相应椎体节段的3D数据。由于存在术后残留风险、恢复风险高或术后复发风险,因此进行了钛合金3D打印椎体植入和机器人立体定向放射治疗。主要观察指标包括症状缓解、椎体稳定性、机器人立体定向手术精度和局部肿瘤控制。所有患者均接受了完整且成功的联合治疗,所有患者均一期愈合,无并发症。机器人放射外科的覆盖精度误差小于0.5毫米,旋转角度误差小于0.5°。治疗毒性有限(主要为1-2级),不良事件少见。所有患者的椎体稳定性和组织相容性评估均符合术后临床要求。对于脊柱损伤后的患者,疼痛症状减轻或消失(93%),治疗后神经功能改善甚至恢复(100%)。在我们的随访期间,大多数肿瘤在局部得到了良好控制(93%)。3D打印椎体植入联合机器人放射外科可能为脊柱肿瘤提供一种新的治疗方法。中国临床试验注册中心:ChiCTR-ONN-17013946。